As of 3:59pm ET
| +2.74 / +4.40%|
The 1 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 76.00, with a high estimate of 76.00 and a low estimate of 76.00. The median estimate represents a +16.83% increase from the last price of 65.05.
The current consensus among 1 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.